Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-cv-02116/USCOURTS-cand-3_05-cv-02116-8/pdf.json

Parties Involved:
Allergan, Inc.
Counter-defendant
Apotex Corp.
Counter-claimant
Apotex, Inc.
Counter-claimant
Roche Palo Alto LLC
Counter-defendant
Syntex (U.S.A.) LLC
Plaintiff

Document Text:

REQUEST FOR IMMEDIATE STATUS CONFERENCE 

CASE NO. 3:05-cv-02116-MJJ 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

ALEXANDER L. BRAINERD (Bar No. 42722) 

KEITH R. WEED (Bar No. 95563) 

CHRISTINE SAUNDERS HASKETT (Bar No. 188053) 

SAMUEL F. ERNST (Bar No. 223963) 

NATHAN E. SHAFROTH (Bar No. 232505) 

HELLER EHRMAN LLP

333 Bush Street, 9th Floor 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6000 

Facsimile: (415) 772-6268 

nathan.shafroth@hellerehrman.com 

Attorneys for Plaintiffs and Counter-Defendants 

ROCHE PALO ALTO LLC and ALLERGAN, INC. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

ROCHE PALO ALTO LLC, formerly known 

as Syntex (U.S.A.) LLC, and ALLERGAN, 

INC., a Delaware corporation, 

Plaintiffs and Counter-Defendants, 

v. 

APOTEX, INC., a Canada corporation, and 

APOTEX CORP., a Delaware corporation, 

Defendants and Counter-Plaintiffs.

 Case No.: 3:05-cv-02116-MJJ 

REQUEST FOR IMMEDIATE STATUS 

CONFERENCE & [PROPOSED] 

ORDER 

The Honorable Martin J. Jenkins

 

Case 3:05-cv-02116-MJJ Document 35 Filed 05/25/2007 Page 1 of 5
 Case 3:05-cv-02116-MJJ Document 36 Filed 06/01/07 Page 1 of 5
 

REQUEST FOR IMMEDIATE STATUS CONFERENCE 

CASE NO. 3:05-cv-02116-MJJ

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

1

Roche Palo Alto LLC (“Roche”) and Allergan, Inc. (“Allergan”) (collectively, “Plaintiffs”) 

request that this case be reopened and that a status conference be scheduled immediately. Counsel 

for Plaintiffs have discussed this request with counsel for Apotex, Inc. and Apotex Corp. (collectively 

“Defendants”), and Defendants’ counsel agrees that an immediate status conference scheduled 

immediately. 

BACKGROUND 

This is an action under 35 U.S.C. section 271(e)(2) for infringement and inducement of 

infringement of U.S. Patent No, 5, 110, 493 (“the ‘493 patent”). Defendants are generic 

pharmaceutical companies who have filed an Abbreviated New Drug Application (“ANDA”) 76-308, 

through which they seek FDA approval to sell a generic 0.4% ketorolac tromethamine ophthalmic 

formulation. Plaintiffs allege that Defendants’ filing of ANDA 76-308 infringes the ‘493 patent. 

The parties have previously litigated another case involving Defendants’ infringement of the 

‘493 patent. That previous case concerned Defendants’ filing of ANDA 76-109, through which 

Defendants sought FDA approval to sell a generic 0.5% ketorolac tromethamine ophthalmic 

formulation, Case No. 3:01-cv-02214. In a Judgment entered on August 18, 2006, this Court found 

that Defendants’ filing of ANDA 76-109 infringed the ‘493 patent and that the ‘493 patent was valid 

and enforceable. The Federal Circuit recently affirmed the Judgment. Defendants currently have 

pending before the Federal Circuit a motion to recall and stay the Federal Circuit’s mandate in Case 

No. 3:01-cv-02214, and for an ex post extension of time to file a petition for rehearing (by panel and 

en banc) of their appeal in that case. 

This case was stayed while Case No. 3:01-cv-02214 proceeded in this Court and on appeal. It 

appears, however, that the Court administratively closed this case. 

Apotex has now indicated that it intends to litigate this case. Time is of the essence. 

Defendants notified Plaintiffs of their filing of ANDA 76-308 on or about April 11, 2005. Therefore, 

in the absence of (a) a decision that ANDA 76-308 infringes the ‘493 patent or (b) a preliminary 

injunction prohibiting Defendants from engaging in the commercial manufacture or sale of the 

Case 3:05-cv-02116-MJJ Document 35 Filed 05/25/2007 Page 2 of 5
 Case 3:05-cv-02116-MJJ Document 36 Filed 06/01/07 Page 2 of 5
 

REQUEST FOR IMMEDIATE STATUS CONFERENCE 

CASE NO. 3:05-cv-02116-MJJ

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2

generic drug covered by ANDA 76-308, the Food and Drug Administration could potentially grant 

final approval of Defendants’ ANDA 76-308 on October 11, 2007. See 21 U.S.C. §355(j)(5)(B)(iii). 

Plaintiffs therefore request that the Court re-open this case and schedule an immediate status 

conference. Defendants do not oppose an immediate status conference, but—through counsel—have 

expressed a preference that such conference be held on a Tuesday or Wednesday. 

Dated: May 25, 2007 HELLER EHRMAN LLP

 By ________/s/_Nathan E. Shafroth____________ 

 Attorneys for Plaintiffs and Counter-Defendants 

 ROCHE PALO ALTO LLC and ALLERGAN, INC. 

Case 3:05-cv-02116-MJJ Document 35 Filed 05/25/2007 Page 3 of 5
 Case 3:05-cv-02116-MJJ Document 36 Filed 06/01/07 Page 3 of 5
 

REQUEST FOR IMMEDIATE STATUS CONFERENCE 

CASE NO. 3:05-cv-02116-MJJ

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

3

[PROPOSED] ORDER 

The Request for an Immediate Status Conference is hereby GRANTED. Counsel for all 

parties are ordered to submit a joint status conference statement on ______________, and to 

appear before the Court for a status conference on _______________. 

Dated:____________________ __________________________________ 

 MARTIN J. JENKINS 

 UNITED STATES DISTRICT JUDGE 

 NORTHERN DISTRICT OF CALIFORNIA 

Case 3:05-cv-02116-MJJ Document 35 Filed 05/25/2007 Page 4 of 5

6/1/07 or ASAP Tues., 6/5/07 at 2:00 p.m. 5/31/2007

Case 3:05-cv-02116-MJJ Document 36 Filed 06/01/07 Page 4 of 5
 

REQUEST FOR IMMEDIATE STATUS CONFERENCE 

CASE NO. 3:05-cv-02116-MJJ

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

4

CERTIFICATE OF SERVICE

I hereby certify that all counsel of record, who are deemed to have consented to electronic 

service are being served this 25th day of May 2007, with a copy of this document via the Court’s 

CM/ECF system. 

Alan H. Bernstein, Esq. ahbernstein@crbcp.com 

Manny D. Pokotilow, Esq. mpokotilow@crbcp.com

Robert S. Silver, Esq. rssilver@crbcp.com 

Mona Gupta, Esq. mgupta@crbcp.com

William J. Castillo, Esq. cuneoc@howrey.com

 By____/s/ Nathan E. Shafroth______ 

 NATHAN E. SHAFROTH 

 

Attorneys for Plaintiffs and Counter-Defendants 

ROCHE PALO ALTO LLC and ALLERGAN, INC. 

Case 3:05-cv-02116-MJJ Document 35 Filed 05/25/2007 Page 5 of 5
 Case 3:05-cv-02116-MJJ Document 36 Filed 06/01/07 Page 5 of 5